Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD80 Kit CLIA

Le kit ELISA CD80 (ABIN6201867) Humain est un kit ELISA Chemiluminescent conçu pour quantifier Humain CD80.
N° du produit ABIN6201867
1.290,21 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 7 à 15 jours ouvrables

Aperçu rapide pour CD80 Kit CLIA (ABIN6201867)

Antigène

Voir toutes CD80 Kits CLIA
CD80

Reactivité

  • 19
  • 16
  • 8
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Humain

Méthode de détection

Chemiluminescent

Type de méthode

Sandwich ELISA

Gamme de detection

78.12 pg/mL - 5000 pg/mL

Application

ELISA

Type d'échantillon

Plasma, Serum, Tissue Homogenate
  • Seuil minimal de détection

    78.12 pg/mL

    Fonction

    B-Lymphocyte Activation Antigen B7-1 CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.

    Analytical Method

    Quantitative

    Sensibilité

    < 33 pg/mL
  • Indications d'application

    Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

    Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

    Standard Form: Lyophilized

    Plaque

    Pre-coated

    Restrictions

    For Research Use only
  • Stock

    4 °C/-20 °C

    Stockage commentaire

    Upon receipt, store the kit according to the storage instruction in the kit's manual.

    Date de péremption

    6 months
  • Antigène Voir toutes CD80 Kits CLIA

    CD80

    Autre désignation

    B-Lymphocyte Activation Antigen B7-1

    Pathways

    TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!